Inhaled corticosteroid-phobia and childhood asthma: Current understanding and management implications

Area of Science:

• Pediatric Pulmonology
• Clinical Psychology
• Public Health

Background:

• Asthma is the most common chronic childhood illness, with inhaled corticosteroids (ICS) as the primary treatment.
• Suboptimal adherence to ICS therapy is a significant challenge in managing pediatric asthma.
• Steroid-phobia, a parental fear of ICS side effects, is prevalent and contributes to treatment non-compliance.

Purpose of the Study:

• To investigate the prevalence and impact of steroid-phobia on pediatric asthma management.
• To identify parental misconceptions regarding ICS side effects.
• To highlight the need for targeted educational interventions for steroid-phobic parents.

Main Methods:

• Literature review and synthesis of existing studies on steroid-phobia in pediatric asthma.
• Analysis of reported parental concerns and their basis in scientific evidence.
• Assessment of the impact of steroid-phobia on ICS compliance and asthma control.

Main Results:

• Steroid-phobia prevalence ranges from 19% to 67%, with common misconceptions about weight gain, bone weakness, addiction, and psychiatric issues.
• While mild growth suppression is a documented side effect, other parental concerns are largely unfounded.
• Steroid-phobia consistently worsens asthma control in children, though its effect on compliance is debated.

Conclusions:

• Steroid-phobia is a significant barrier to effective pediatric asthma management, impacting children's health outcomes.
• Current asthma education programs may not effectively address the specific needs of steroid-phobic parents.
• Further research is crucial to develop and evaluate targeted interventions to reduce steroid-phobia and improve ICS adherence and asthma control in children.